Glucocorticoid regulation of the vitamin D receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 372-375

  Hidalgo, Alejandro A ^a,b   Trump, Donald L ^b   Johnson, Candace S ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Dexamethasone; Glucocorticoids; Vdr; Vitamin D

Indexed keywords

ANDROSTANOLONE; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 24A1; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR; LUCIFERASE; METRIBOLONE; STEROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; COLECALCIFEROL 24 HYDROXYLASE; CYP24A1 PROTEIN, HUMAN; CYP24A1 PROTEIN, MOUSE; STEROID MONOOXYGENASE;

ARTICLE; ASSAY; CHROMATIN IMMUNOPRECIPITATION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERCALCEMIA; METABOLISM; MOUSE; SQUAMOUS CELL CARCINOMA;

ANIMALS; CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CHROMATIN IMMUNOPRECIPITATION; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYPERCALCEMIA; MICE; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; RESPONSE ELEMENTS; STEROID HYDROXYLASES; VITAMIN D3 24-HYDROXYLASE;

EID: 77954715155     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.081     Document Type: Article

References (27)

1. Kallay E., Pietschmann P., Toyokuni S., Bajna E., Hahn P., Mazzucco K., Bieglmayer C., Kato S., Cross H.S. Characterization of a vitamin d receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 2001, 22:1429-1435.
2. Deeb K.K., Trump D.L., Johnson C.S. Vitamin d signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007, 7:684-700.
3. Chung I., Han G., Seshadri M., Gillard B.M., Yu W.D., Foster B.A., Trump D.L., Johnson C.S. Role of vitamin d receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res. 2009, 69:967-975.
4. Chung I., Yu W.D., Karpf A.R., Flynn G., Bernardi R.J., Modzelewski R.A., Johnson C.S., Trump D.L. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. J. Steroid Biochem. Mol. Biol. 2007, 103:768-770.
5. Flynn G., Chung I., Yu W.D., Romano M., Modzelewski R.A., Johnson C.S., Trump D.L. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology 2006, 70:447-457.
6. Byrne I.M., Flanagan L., Tenniswood M.P., Welsh J. Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin d receptor gene. Endocrinology 2000, 141:2829-2836.
7. Jehan F., DeLuca H.F. The mouse vitamin d receptor is mainly expressed through an sp1-driven promoter in vivo. Arch. Biochem. Biophys. 2000, 377:273-283.
8. Arriagada G., Paredes R., Olate J., van Wijnen A., Lian J.B., Stein G.S., Stein J.L., Onate S., Montecino M. Phosphorylation at serine 208 of the 1alpha,25-dihydroxy vitamin d3 receptor modulates the interaction with transcriptional coactivators. J. Steroid Biochem. Mol. Biol. 2007, 103:425-429.
9. Hsieh J.C., Jurutka P.W., Galligan M.A., Terpening C.M., Haussler C.A., Samuels D.S., Shimizu Y., Shimizu N., Haussler M.R. Human vitamin d receptor is selectively phosphorylated by protein kinase c on serine 51, a residue crucial to its trans-activation function. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:9315-9319.
10. Hsieh J.C., Jurutka P.W., Nakajima S., Galligan M.A., Haussler C.A., Shimizu Y., Shimizu N., Whitfield G.K., Haussler M.R. Phosphorylation of the human vitamin d receptor by protein kinase c. Biochemical and functional evaluation of the serine 51 recognition site. J. Biol. Chem. 1993, 268:15118-15126.
11. Mohri T., Nakajima M., Takagi S., Komagata S., Yokoi T. MicroRNA regulates human vitamin d receptor. Int. J. Cancer 2009, 125:1328-1333.
12. Lee G.S., Choi K.C., Jeung E.B. Glucocorticoids differentially regulate expression of duodenal and renal calbindin-d9k through glucocorticoid receptor-mediated pathway in mouse model. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E299-E307.
13. Trump D.L., Potter D.M., Muindi J., Brufsky A., Johnson C.S. Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin d3) and dexamethasone in androgen-independent prostate cancer. Cancer 2006, 106:2136-2142.
14. Bernardi R.J., Trump D.L., Yu W.D., McGuire T.F., Hershberger P.A., Johnson C.S. Combination of 1alpha,25-dihydroxyvitamin d(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and erk/akt signaling. Clin. Cancer Res. 2001, 7:4164-4173.
15. Yu W.D., McElwain M.C., Modzelewski R.A., Russell D.M., Smith D.C., Trump D.L., Johnson C.S. Enhancement of 1,25-dihydroxyvitamin d3-mediated antitumor activity with dexamethasone. J. Natl. Cancer Inst. 1998, 90:134-141.
16. Carlberg C. Rxr-independent action of the receptors for thyroid hormone, retinoid acid and vitamin d on inverted palindromes. Biochem. Biophys. Res. Commun. 1993, 195:1345-1353.
17. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin d receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
18. Holick M.F. Vitamin d and bone health. J. Nutr. 1996, 126:1159S-1164S.
19. Sun X., Zemel M.B. 1alpha,25-dihydroxyvitamin d and corticosteroid regulate adipocyte nuclear vitamin d receptor. Int. J. Obes. (Lond.) 2008, 32:1305-1311.
20. Hirst M., Feldman D. Glucocorticoids down-regulate the number of 1,25-dihydroxyvitamin d3 receptors in mouse intestine. Biochem. Biophys. Res. Commun. 1982, 105:1590-1596.
21. Kim M.H., Lee G.S., Jung E.M., Choi K.C., Jeung E.B. The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder. Life Sci. 2009, 85:146-152.
22. Kim M.H., Lee G.S., Jung E.M., Choi K.C., Oh G.T., Jeung E.B. Dexamethasone differentially regulates renal and duodenal calcium-processing genes in calbindin-d9k and -d28k knockout mice. Exp. Physiol. 2009, 94:138-151.
23. Yemelyanov A., Czwornog J., Chebotaev D., Karseladze A., Kulevitch E., Yang X., Budunova I. Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 2007, 26:1885-1896.
24. Podvinec M., Kaufmann M.R., Handschin C., Meyer U.A. Nubiscan, an in silico approach for prediction of nuclear receptor response elements. Mol. Endocrinol. 2002, 16:1269-1279.
25. Halsall J.A., Osborne J.E., Hutchinson P.E., Pringle J.H. In silico analysis of the 5' region of the vitamin d receptor gene: functional implications of evolutionary conservation. J. Steroid Biochem. Mol. Biol. 2007, 103:352-356.
26. Akeno N., Matsunuma A., Maeda T., Kawane T., Horiuchi N. Regulation of vitamin d-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J. Endocrinol. 2000, 164:339-348.
27. Zella L.A., Meyer M.B., Nerenz R.D., Lee S.M., Martowicz M.L., Pike J.W. Multifunctional enhancers regulate mouse and human vitamin d receptor gene transcription. Mol. Endocrinol. 2010, 24(1):128-147.